First Choice Healthcare Solutions, Inc. (OTC: FCHS) has entered into a business combination agreement, valuing the company at up to approximately $650 million. This strategic move, which includes FCHS becoming a subsidiary of Wellgevity 360, Inc., aims to expand its functional health and regenerative medicine operations, driving significant investor interest as shares rose 300.0% year-to-date.

Key Highlights

  • First Choice Healthcare Solutions (OTC: FCHS) has been valued at up to approximately $650 million through a new business combination agreement.
  • The company will merge with a subsidiary of Westin Acquisition Corp. which will undergo domestication and be renamed Wellgevity 360, Inc.
  • Shares of FCHS have climbed 300.0% year-to-date and 200.0% over the past month following the announcement.

First Choice Healthcare Solutions, Inc. (OTC: FCHS) has officially entered a significant business combination agreement, valuing the company at up to approximately $650 million. Announced on July 22, 2026, the transaction will see the healthcare‑services provider merge into a subsidiary of Westin Acquisition Corp. a company organized under Cayman Islands law that will domesticate and adopt the name Wellgevity 360, Inc. Following completion, FCHS will become a wholly‑owned subsidiary of the newly formed Wellgevity 360, Inc. positioning the combined entity for a broader role in functional health, longevity, and regenerative medicine.

The restructuring is intended to harness integrated operations to support growth and enhance shareholder value.

Strategic Merger Valued at $650 Million

The definitive business combination agreement sets an equity valuation for First Choice Healthcare Solutions of up to approximately $650 million. This valuation underlies the merger with a subsidiary of Westin Acquisition Corp. which will first domesticate from its offshore jurisdiction to Nevada, thereby creating a domestic corporate platform known as “Wellgevity 360, Inc.” (referred to as “PubCo” in the agreement). This corporate realignment establishes a clear U.S.

legal and operational foundation for the combined enterprise, facilitating future expansion and governance within the evolving healthcare‑services sector. These acquisitions, collectively described as the “Pointe Med Entities,” are slated to close contemporaneously with the main business combination, instantly enlarging the operational scope of the merged company. At the same time, the company secured a private investment in public equity (PIPE) arrangement.

This infusion of capital is expected to provide the combined entity with additional financial flexibility to integrate the newly acquired businesses and to fund further strategic initiatives within its niche healthcare markets.

Investor Optimism Drives Share Performance

The announcement of the business combination has generated notable investor enthusiasm for First Choice Healthcare Solutions. While the exact trading price is not disclosed, the market response has been pronounced, with FCHS shares recording a 300.0% increase year‑to‑date and a 200.0% rise over the past month. This movement reflects confidence that the merger, accompanying acquisitions, and PIPE funding together constitute a strong catalyst for future value creation and market leadership in functional health and longevity sectors.

Next Steps: Regulatory Review and Shareholder Approvals

Completion of the transaction remains subject to customary closing conditions, including the receipt of required governmental and third‑party approvals and the absence of adverse regulatory actions. As a key procedural step, Westin Acquisition Corp. the “Parent” entity, must prepare and file a registration statement on Form S‑4 with the U.S. Securities and Exchange Commission.

Market participants will be monitoring the progress of this filing and the subsequent shareholder vote, which together represent the critical milestones toward finalizing this complex and transformative transaction.

Analysis based on the Form 8-K filed 28 July 2026; figures verified against the filing and live market data.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.